AZB & Partners advised Novartis AG on this transaction.
The transaction team consisted of Darshika Kothari (Senior Partner), Kritika Agarwal (Partner), Arnav Shah (Counsel), Associates Ashwin Vardarajan and Siddharth Tandon. They were supported by the following:-
SEBI regulatory aspects: Harini Balaji (Senior Consultant), Abhilash Chandran (Partner), Prerak Ved (Partner), Associates Akash Kumar Prasad and Hardik Batra;
Litigation aspects: Rajendra Barot (Senior Partner), Prabhav Shroff (Partner), Ayush Chaddha (Senior Associate);
Tax aspects: Aditya Singh Chandel (Partner), Suhail Bansal (Senior Associate), Sarvagya Bilgaiyan (Senior Associate);
Due diligence and other aspects: Nishanth Ravindran (Partner), Nandan Pendsey (Partner), Avinash Subramanian (Partner), Shailesh Singh (Senior Associate), Rhea Ghanshani (Senior Associate), Riddhi Tulshian (Senior Associate), Aditya Mukherjee (Senior Associate), Harshit Jaiswal (Senior Associate), Jay Shah (Senior Associate), Associates Apurva Vats, Deepti Prabhu, Parvathy Suresh, Vivek Ilawat and Pratyush Chaturvedi;
Antitrust aspects: Bharat Budholia (Senior Partner), Kirthi Srinivas (Partner), Varun Thakur (Senior Associate), Shivangi Pradhan (Associate).